Mpm Asset Management LLC Harpoon Therapeutics, Inc. Transaction History

Mpm Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.74 - $8.5 $2.09 Million - $24 Million	-2,818,252 Reduced 90.0%	313,136 $1.26 Million
Q3 2021 Nov 15, 2021	BUY	$7.88 - $14.0 $8,833 - $15,694	1,121 Added 0.04%	3,131,388 $24.7 Million
Q2 2021 Aug 13, 2021	SELL	$13.81 - $23.25 $1.49 Million - $2.51 Million	-108,039 Reduced 3.34%	3,130,267 $43.4 Million
Q1 2021 May 13, 2021	SELL	$17.65 - $24.16 $22.7 Million - $31.1 Million	-1,286,119 Reduced 28.43%	3,238,306 $67.7 Million
Q1 2019 May 29, 2019	BUY	$9.47 - $17.01 $3.05 Million - $5.48 Million	322,063 Added 7.66%	4,524,425 $42.8 Million
Q1 2019 May 13, 2019	BUY	$9.47 - $17.01 $39.8 Million - $71.5 Million	4,202,362 New	4,202,362 $39.8 Million

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Mpm Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Mpm Asset Management LLC with notifications on news.